ECOR electroCore, Inc. Stock Quote

ECOR [NASD]

Healthcare | Medical Instruments & Supplies | USA

Index	-	P/E	-	EPS (ttm)	-0.27	Insider Own	1.50%	Shs Outstand	70.67M	Perf Week	47.84%
Market Cap	22.90M	Forward P/E	-	EPS next Y	-0.24	Insider Trans	23.83%	Shs Float	62.15M	Perf Month	-21.00%
Income	-17.40M	PEG	-	EPS next Q	-0.07	Inst Own	20.20%	Short Float	2.35%	Perf Quarter	-29.70%
Sales	6.10M	P/S	3.75	EPS this Y	51.70%	Inst Trans	1.43%	Short Ratio	3.80	Perf Half Y	-52.92%
Book/sh	0.45	P/B	0.87	EPS next Y	22.20%	ROA	-43.80%	Target Price	2.80	Perf Year	-75.57%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-52.40%	52W Range	0.27 - 1.85	Perf YTD	-32.46%
Dividend	-	P/FCF	-	EPS past 5Y	12.10%	ROI	-47.10%	52W High	-78.42%	Beta	1.17
Dividend %	-	Quick Ratio	6.60	Sales past 5Y	84.60%	Gross Margin	77.50%	52W Low	50.62%	ATR	0.04
Employees	52	Current Ratio	6.90	Sales Q/Q	58.30%	Oper. Margin	-	RSI (14)	47.24	Volatility	12.87% 9.74%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	30.10%	Profit Margin	-	Rel Volume	0.19	Prev Close	0.39
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 05 AMC	Payout	-	Avg Volume	383.38K	Price	0.40
Recom	2.00	SMA20	1.67%	SMA50	-18.36%	SMA200	-45.93%	Volume	31,005	Change	1.50%

Aug-14-20

Upgrade

BTIG Research

Neutral → Buy

$3.50

Nov-14-19

Downgrade

JMP Securities

Mkt Outperform → Mkt Perform

Sep-26-19

Resumed

Cantor Fitzgerald

Neutral

May-30-19

Downgrade

Cantor Fitzgerald

Overweight → Neutral

May-15-19

Downgrade

BTIG Research

Buy → Neutral

May-09-19

Initiated

Noble Capital Markets

Outperform

Sep-21-18

Initiated

Cantor Fitzgerald

Overweight

May-18-22 08:00AM	electroCore to Participate at Upcoming Investor Conferences GlobeNewswire
May-14-22 10:40AM	We're Keeping An Eye On electroCore's (NASDAQ:ECOR) Cash Burn Rate Simply Wall St.
May-06-22 08:26AM	ECOR: First Quarter 2022 Financial and Operational Results Zacks Small Cap Research
08:25AM	ECOR: First Quarter 2022 Financial and Operational Results Zacks Small Cap Research
May-05-22 04:00PM	electroCore Announces Record First Quarter 2022 Financial Results GlobeNewswire
Apr-28-22 08:00AM	electroCore to Announce First Quarter 2022 Financial Results on May 5 GlobeNewswire -12.27%
Apr-26-22 08:00AM	electroCore Completes Sale of New Jersey Tax Benefits GlobeNewswire
Apr-21-22 08:00AM	electroCore Announces Publication of Investigator-Initiated Trial Data for SAVIOR-1 in COVID-19 Patients in Frontiers in Neurology GlobeNewswire
Apr-19-22 08:00AM	gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Selected for Department of Defense Biotech Optimized for Operational Solutions and Tactics (BOOST) Program GlobeNewswire
Apr-12-22 08:00AM	electroCore Provides Business Update and Select First Quarter 2022 Financial Guidance GlobeNewswire
Apr-05-22 08:00AM	electroCore Announces Exclusive License Agreement with Teijin for Japan Territory GlobeNewswire
Mar-23-22 08:00AM	electroCore Announces Dr. Peter Staats to Keynote the Fifth Annual Bioelectronic Medicine Forum in New York GlobeNewswire
Mar-22-22 08:00AM	electroCore to Present at 2022 Maxim Virtual Growth Conference GlobeNewswire +6.17%
Mar-14-22 05:56AM	ECOR: 2021 Results Zacks Small Cap Research -6.88%
Mar-10-22 04:01PM	electroCore Announces Fourth Quarter and Full Year 2021 Financial Results GlobeNewswire
Mar-09-22 11:30AM	electroCore Announces Changes to its Board of Directors GlobeNewswire
Mar-07-22 04:01PM	electroCore to Present at 34th Annual Roth Conference GlobeNewswire
Mar-03-22 08:00AM	electroCore to Announce Fourth Quarter and Year Ended December 31, 2021 Financial Results on Thursday, March 10 GlobeNewswire
Feb-22-22 07:40AM	ECOR: Different Strokes for Different Folks Zacks Small Cap Research
Feb-09-22 08:00AM	Data Presented at 2022 International Stroke Congress Suggests Role for Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Stroke GlobeNewswire
Feb-01-22 08:00AM	electroCore, Inc. Announces Completion of Enrollment in the TRANSIT Study of non-Invasive Vagus Nerve Stimulation (nVNS) in Post-Operative Ileus GlobeNewswire
Jan-25-22 08:00AM	electroCore, Inc. Announces Three Abstracts to be Presented at International Stroke Conference 2022 GlobeNewswire
Jan-18-22 08:00AM	electroCore Announces Shareholder Letter and Full-Year 2021 Business Update GlobeNewswire +8.29%
04:32AM	ECOR: New Distribution Agreements Complement E-Commerce Initiative Zacks Small Cap Research
Jan-12-22 05:27PM	ECOR Stock Alert: Why Is electroCore Soaring Today? InvestorPlace +64.03%
08:00AM	gammaCore Non-Invasive Vagus Nerve Stimulation(nVNS) Receives Breakthrough Device Designation for Treatment of Posttraumatic Stress Disorder (PTSD) GlobeNewswire
Jan-11-22 08:00AM	electroCore, Inc. Broadens Patient Access to gammaCore with Launch of U.S. Telehealth Portal and Online Store GlobeNewswire
Jan-10-22 04:01PM	electroCore Announces Publication of PREMIUM II Trial of gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) for the Prevention of Migraine GlobeNewswire
Jan-04-22 08:00AM	electroCore to Present at H.C. Wainwright BIOCONNECT Virtual Conference GlobeNewswire
Dec-16-21 08:00AM	electroCore, Inc. Provides Update on Global Distribution Partners GlobeNewswire
Dec-15-21 08:00AM	electroCore, Inc. Announces The Launch of a New Online Shop in the United Kingdom GlobeNewswire
Dec-14-21 08:00AM	electroCore, Inc. Provides Update on nVNS to Treat Post Traumatic Stress Disorder GlobeNewswire -5.75%
Dec-13-21 08:55AM	electroCore Announces New Patent for Stroke and TIA Treatment GlobeNewswire
Nov-11-21 08:00AM	electroCore to Participate at Canaccord Genuity MedTech & Diagnostics Forum GlobeNewswire
Nov-08-21 06:41AM	ECOR: Third Quarter Results Zacks Small Cap Research
Nov-04-21 04:01PM	electroCore Announces Third Quarter 2021 Financial Results GlobeNewswire
09:04AM	Quite a few insiders invested in electroCore, Inc. (NASDAQ:ECOR) last year which is positive news for shareholders Simply Wall St.
Oct-21-21 08:00AM	electroCore to Announce Third Quarter 2021 Financial Results on Thursday, November 4th GlobeNewswire
Oct-20-21 08:00AM	electroCore Announces Publication Reviewing the Prescribing of gammaCore for the Treatment of Cluster Headache in England GlobeNewswire
Oct-14-21 08:00AM	electroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine GlobeNewswire
Oct-12-21 08:00AM	electroCore Provides Business Update and Select Third Quarter 2021 Financial Guidance GlobeNewswire
Oct-07-21 08:00AM	electroCore Announces Acceptance of Motion to Dismiss in the Federal Court Securities Class Action Suit GlobeNewswire
Oct-04-21 04:30PM	36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021 ACCESSWIRE
Sep-30-21 09:05AM	electroCore Presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference GlobeNewswire
Sep-29-21 08:00AM	electroCore Announces Open Access and Submission of Manuscript from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients GlobeNewswire
Sep-23-21 10:50AM	2 Strong Buy Penny Stocks That Are Headed to a Triple-Digit Gain TipRanks +9.28%
08:00AM	electroCore to Participate at Upcoming Investor Conferences GlobeNewswire
Sep-20-21 08:00AM	electroCore Announces Peter Cuneo as Board Chairman GlobeNewswire
Sep-14-21 08:00AM	electroCore Announces 510(k) Clearance of gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Paroxysmal Hemicrania and Hemicrania Continua GlobeNewswire -5.91%
Aug-31-21 08:00AM	electroCore to Present at the HC Wainwright 23rd Annual Global Investment Conference GlobeNewswire
Aug-24-21 08:00AM	electroCore Announces New Reseller Agreement with Red One Medical Devices, LLC. GlobeNewswire +7.20%
Aug-16-21 07:21AM	electroCore (NASDAQ:ECOR) Is In A Good Position To Deliver On Growth Plans Simply Wall St. -5.33%
Aug-10-21 08:00AM	Study of Non-Invasive Vagus Nerve Stimulation (nVNS) Shows Improvement in PTSD Symptoms and Decreased Inflammatory Response to Stress GlobeNewswire
Aug-09-21 06:23AM	ECOR: Impressive Growth: Invigorating Guidance Zacks Small Cap Research
Aug-05-21 04:01PM	electroCore Announces Second Quarter 2021 Financial Results GlobeNewswire
Aug-02-21 08:00AM	electroCore to Present at the Canaccord Genuity Growth Conference GlobeNewswire
Jul-27-21 08:50AM	ElectroCore Stock Is Trading Higher As Ladenburg Initiates Coverage With $3 Price Target, Buy Rating Benzinga
08:00AM	electroCore Announces Issuance of New Patent for Migraine Treatment using Smartphones GlobeNewswire
Jul-22-21 08:00AM	electroCore to Announce Second Quarter 2021 Financial Results on Thursday, August 5th GlobeNewswire
Jul-19-21 08:00AM	electroCore announces Dr. Peter Staats to receive Lifetime Achievement Award from the American Society of Pain and Neuroscience GlobeNewswire
Jul-13-21 08:00AM	electroCore Provides Business Update and Select Second Quarter 2021 Financial Guidance GlobeNewswire
Jul-09-21 08:00AM	electroCore to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference GlobeNewswire +5.61%
Jun-30-21 11:46AM	ElectroCore Stock Dives On $18M Equity Raise Issued At Deep Discount Of 32% Benzinga -20.13%
08:30AM	electroCore Announces Pricing of $18.0 Million Public Offering of Common Stock GlobeNewswire
Jun-29-21 04:01PM	electroCore Announces Proposed Public Offering of Common Stock GlobeNewswire -5.70%
Jun-24-21 08:00AM	electroCore Announces Publication of Study on the Effect of non-invasive Vagus Nerve Stimulation (nVNS) on Cognitive Performance Caused by Sleep Deprivation GlobeNewswire
Jun-23-21 08:00AM	electroCore, Inc. Announces Exclusive Distribution Agreement with Kromax For Taiwan and China GlobeNewswire
Jun-22-21 09:48PM	Where Do Hedge Funds Stand On electroCore, Inc. (ECOR)? Insider Monkey
Jun-16-21 08:00AM	electroCore to Join Russell Microcap® Index GlobeNewswire
Jun-09-21 08:00AM	electroCore Completes Sale of $1.4 Million of NJ NOL Tax Benefits GlobeNewswire
Jun-02-21 07:30AM	electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Improve Clinical Outcomes and Molecular Biomarkers in Parkinsons Disease Patients GlobeNewswire
May-27-21 07:15PM	35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021 ACCESSWIRE +5.52%
May-26-21 07:30AM	electroCore to Present at Investor Conferences in June GlobeNewswire
May-17-21 09:05AM	ECOR: 1Q:21 Results Zacks Small Cap Research
May-06-21 04:12PM	electroCore Announces First Quarter 2021 Financial Results GlobeNewswire -7.27%
02:30PM	electroCore, Inc. to Host Earnings Call ACCESSWIRE
May-04-21 08:00AM	electroCore, Inc. Announces U.S. Department of Veterans Affairs Study of gammaCore Sapphire (Non-Invasive Vagus Nerve Stimulator) for the Treatment of Post-Traumatic Headache GlobeNewswire
Apr-29-21 08:00AM	electroCore to Announce First Quarter 2021 Financial Results on Thursday, May 6 GlobeNewswire
Apr-26-21 08:00AM	electroCore, Inc. Announces Johns Hopkins University School of Medicine Study of Non-Invasive Vagus Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients with Gastroparesis and Related Disorders GlobeNewswire +7.78%
Apr-20-21 08:00AM	electroCore, Inc. Announces Exclusive Distribution Agreement with East Agency For Qatar GlobeNewswire -5.95%
Apr-15-21 07:59AM	electroCore Announces Publication in Nature Reviews: Neurology Highlighting the Role of Non-Invasive Vagus Nerve Stimulation (nVNS) as an Emerging Treatment for Cluster Headache GlobeNewswire
Apr-13-21 07:59AM	electroCore Provides Business Update and Select First Quarter 2021 Financial Guidance GlobeNewswire
Apr-08-21 09:07AM	ElectroCore's Stock Is Trading Higher As nVNS Decreases Certain COVID-19-Associated Biomarkers Benzinga +5.10%
07:59AM	electroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients GlobeNewswire
Apr-05-21 09:34AM	ElectroCore's Stock Is Trading Higher After Its Nerve Stimulator Wins Canadian Approval For Migraine Benzinga
07:59AM	electroCore, Inc. Announces Regulatory Approval in Canada GlobeNewswire
Mar-23-21 08:00AM	electroCore, Inc. Announces Exclusive Distribution Agreement with Silvert Medical Nv-Sa. For Western Europe GlobeNewswire
Mar-22-21 08:18AM	ECOR: More Distribution Agreements to Come Zacks Small Cap Research
Mar-15-21 08:56AM	Chief Medical Officer of electroCore, Inc. Peter Staats, M.D. Describes Potential At-Home Solutions to Reduce Common COVID-19 Symptoms Business Wire
Mar-11-21 04:05PM	electroCore Announces Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire
02:30PM	electroCore, Inc. to Host Earnings Call ACCESSWIRE
Mar-04-21 08:30AM	electroCore to Announce Fourth Quarter and Year Ended December 31, 2020 Financial Results on Thursday, March 11 GlobeNewswire -12.89%
Mar-03-21 04:30PM	electroCore to Participate at Two Upcoming Investor Conferences GlobeNewswire -10.71%
Feb-28-21 04:00PM	electroCore Inc. Announces Exclusive Distribution Agreement with Medistar Following Regulatory Approval in Australia GlobeNewswire
Feb-24-21 07:45AM	Non-Invasive Vagus Nerve Stimulation (nVNS) Enters New Stage of COVID-19 Research Business Wire +13.27%
Feb-23-21 08:00AM	electroCore Announces Two-Year Extension of gammaCore Listing in the NHS Supply Chain Catalogue GlobeNewswire -14.92%
Feb-18-21 02:53AM	If You Had Bought electroCore (NASDAQ:ECOR) Shares A Year Ago You'd Have Earned 147% Returns Simply Wall St.
Feb-16-21 08:00AM	electroCore Announces 510(k) Clearance of gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Adolescent Migraine GlobeNewswire
05:53AM	ECOR: Multiple Irons in the Fire Zacks Small Cap Research
Feb-11-21 08:00AM	electroCore Announces Completion of Enrollment in SAVIOR-1 Study of Non-Invasive Vagus Nerve Stimulation (nVNS) in COVID-19 Patients Exhibiting Respiratory Symptoms GlobeNewswire -5.15%

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Rockaway, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Errico Thomas J.	Director	May 18	Buy	0.40	42,032	16,746	1,411,503	May 19 09:00 PM
Errico Thomas J.	Director	May 17	Buy	0.39	42,771	16,741	1,369,471	May 19 09:00 PM
GANDOLFO JOHN P	Director	May 17	Buy	0.36	15,000	5,400	19,000	May 18 08:30 AM
Goldberger Daniel S	Chief Executive Officer	May 16	Buy	0.34	28,208	9,585	328,516	May 17 04:05 PM
POSNER BRIAN M	Chief Financial Officer	Dec 10	Buy	0.75	10,000	7,500	96,555	Dec 13 08:31 AM
Goldberger Daniel S	Chief Executive Officer	Dec 07	Buy	0.71	15,000	10,641	300,308	Dec 08 09:00 AM
Goldberger Daniel S	Chief Executive Officer	Nov 23	Buy	0.75	15,000	11,247	285,308	Nov 26 02:31 PM
POSNER BRIAN M	Chief Financial Officer	Nov 09	Buy	0.96	10,000	9,600	86,555	Nov 10 08:01 AM
Goldberger Daniel S	Chief Executive Officer	Oct 01	Option Exercise	0.00	53,764	0	270,308	Oct 05 08:00 AM
POSNER BRIAN M	Chief Financial Officer	Aug 17	Sale	0.92	6,478	5,960	76,555	Aug 19 05:19 PM
Errico Thomas J.	Director	Jul 02	Buy	1.00	50,000	50,000	1,326,700	Jul 07 05:00 PM
Goldberger Daniel S	Chief Executive Officer	Jul 02	Buy	1.00	50,000	50,000	216,544	Jul 07 05:01 PM
Moody Trevor J	Director	Jul 02	Buy	1.00	100,000	100,000	373,455	Jul 07 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience